Edition:
United States

Grifols SA (GRLS.MC)

GRLS.MC on Madrid SE C.A.T.S.

19.21EUR
16 Jan 2017
Change (% chg)

€-0.37 (-1.89%)
Prev Close
€19.58
Open
€19.50
Day's High
€19.58
Day's Low
€19.18
Volume
569,791
Avg. Vol
795,736
52-wk High
€20.70
52-wk Low
€16.48

Latest Key Developments (Source: Significant Developments)

Grifols buys 49 pct in US-based Access Biologicals for $51 million
Thursday, 12 Jan 2017 02:21am EST 

Grifols SA : Invests in US-based Access Biologicals via acquisition of 49 percent of its voting rights for $51 million .Negotiated purchase option for remaining 51 percent in 2022.  Full Article

Grifols starts refinancing of part of its bank debt
Tuesday, 10 Jan 2017 07:19am EST 

Grifols SA : Starts refinancing process of part of its bank debt for a total amount of $6.3 billion .The refinancing is assured by Nomura, Bank of America, Merrill Lynch, Goldman Sachs and HSBC.  Full Article

Hologic to divest blood screening business to partner Grifols for $1.85 bln
Wednesday, 14 Dec 2016 04:01pm EST 

Hologic Inc : Expects to update its financial guidance for fiscal 2017 after transaction closes . Transaction has been approved by boards of directors of both companies. . For fiscal 2017 co's share of blood screening business was forecast to contribute $240 million revenue, GAAP EPS of $0.19, and non-GAAP EPS of $0.34 .Hologic to divest blood screening business to partner Grifols for $1.85 billion.  Full Article

Grifols 9-month net profit rises to 406.1 mln euros
Tuesday, 8 Nov 2016 02:21am EST 

Grifols SA : 9-month net profit 406.1 million euros ($448.5 million)versus 401.6 million euros year ago . 9-month EBITDA 842.9 million euros versus 856.8 million euros year ago .9-month net sales 2.95 billion euros versus 2.87 billion euros year ago.  Full Article

Grifols says US prosecutor will not pursue case against Grifols
Friday, 7 Oct 2016 02:35am EDT 

Grifols SA :Says United States Department of Justice closes investigation on possible violations in Foreign Corrupt Practices Act against Grifols with declination to prosecute.  Full Article

Grifols' phase I Alzheimer vaccine study shows good safety profile, tolerability
Monday, 1 Aug 2016 06:15am EDT 

Grifols SA : Says unit Araclon Biotech presents phase I Alzheimer vaccine results showing good safety profile and tolerability . Says blind phase I study does not evaluate the effectiveness of treatment Further company coverage: [GRLS.MC] (Gdynia Newsroom) ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;)).  Full Article

Grifols reports H1 EBITDA at 553.6 mln euros
Thursday, 28 Jul 2016 02:44am EDT 

Grifols : H1 net profit 264.4 million euros ($293.1 million) versus 256 million euros in Reuters poll . H1 EBITDA 553.6 million euros versus 564 million euros in reuters poll .H1 net sales 1.95 billion euros versus 1.90 billion euros year ago.  Full Article

Grifols to buy a 48,000 square meter plot of land
Friday, 22 Jul 2016 05:14am EDT 

Grifols SA : To buy a plot of 48,716 square meters to expand its production facilities in Barcelona . Expects to start works on the new polygon in 2018 and complete them in 2019 Further company coverage: [GRLS.MC] (Gdynia Newsroom) ((gdynia.newsroom@thomsonreuters.com; +48 58 7720920;)).  Full Article

Hologic, Grifols say FDA approves Zika diagnostic test
Monday, 20 Jun 2016 08:00am EDT 

Hologic , Grifols : FDA has approved use of Procleix Zika virus blood screening assay on Procleix panther system under agency's investigational new drug study protocol .FDA approves use of the Procleix zika virus assay from Hologic and Grifols to screen the US blood supply under an IND study protocol.  Full Article

Spain's Grifols targets 1.2 bln euro investments until 2020
Thursday, 2 Jun 2016 05:12am EDT 

Grifols SA :Says it is targeting investments of 1.2 billion euros ($1.4 billion) until 2020.  Full Article

BRIEF-Grifols buys 49 pct in US-based Access Biologicals for $51 million

* Invests in US-based Access Biologicals via acquisition of 49 percent of its voting rights for $51 million